Efficacy and Safety of Deep Transcranial Magnetic Stimulation Versus High-Frequency Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder: A Systematic Review-Reference-Cited by-同舟云学术

Efficacy and Safety of Deep Transcranial Magnetic Stimulation Versus High-Frequency Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder: A Systematic Review

Published:2024-08-05 Issue: Volume: Page:
ISSN:2196-2979
Container-title:Current Behavioral Neuroscience Reports
language:en
Short-container-title:Curr Behav Neurosci Rep

Author:

Zhang Nan,Mo Yu,Lan Xian-Jun,Liu Qi-Man,Li Wen-Xiu,Huang Xing-Bing,Wu Hua-Wang,Xu Shi-Chao,Li Shu-Yun,Yang Xin-Hu,Zheng Wei

Funder

the National Natural Science Foundation of China

Scientific Research Project of Guangzhou Bureau of Education

Guangzhou Health Science and Technology Project

Guangzhou Science and Technology Project of traditional Chinese Medicine and integrated traditional Chinese and Western medicine

China International Medical Exchange Foundation

Science and Technology Program Project of Guangzhou

the Science and Technology Program of Guangzhou

Science and Technology Planning Project of Liwan District of Guangzhou

The Natural Science Foundation Program of Guangdong

Guangzhou Municipal Key Discipline in Medicine

Guangzhou High-level Clinical Key Specialty, Department of Emergency Medicine of National clinical key specialty, and Guangzhou Research-oriented Hospital

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40473-024-00281-y.pdf

Reference51 articles.

1. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet (London England). 2020;396:1204–22. https://doi.org/10.1016/s0140-6736(20)30925-9

2. Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T, Whiteford HA. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013;43:471–81. https://doi.org/10.1017/s0033291712001511

3. Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P, Furukawa TA, Kessler RC, Kohrt BA, Maj M, et al. Time for united action on depression: a lancet-world psychiatric association commission. Lancet (London England). 2022;399:957–1022. https://doi.org/10.1016/s0140-6736(21)02141-3

4. Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry: Official J World Psychiatric Association (WPA). 2014;13:153–60. https://doi.org/10.1002/wps.20128

5. Chen C, Shan W. Pharmacological and non-pharmacological treatments for major depressive disorder in adults: a systematic review and network meta-analysis. Psychiatry Res. 2019;281:112595. https://doi.org/10.1016/j.psychres.2019.112595